Andrei Pop, MD
Interventional Cardiology · Elk Grove Village, ILNPI 1417156365
Payments from drug & device makers
Across 1,139 payments — averaging $1627.73 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Edwards Lifesciences$1.7M
- Inari Medical, Inc.$62K
- Endologix LLC$41K
- W. L. Gore & Associates, Inc.$19K
- Shockwave Medical, Inc$15K
- Abbott$4K
- plus $13K from 28 others
Across 5 payments — averaging $620.40 each. Payments tied to a research study. These frequently flow through the physician to a hospital or research institution rather than to the physician personally.
- Cook Research Incorporated$3K
What the payments were for
- Consulting fees$667,83774%
- Speaking & faculty fees$97,83811%
- Travel & lodging$98,91411%
- Food & beverage$33,9234%
- Education$1,7700%
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Edwards Lifesciences | 804 | $1,701,317 |
| Inari Medical, Inc. | 48 | $61,573 |
| Endologix LLC | 19 | $40,508 |
| W. L. Gore & Associates, Inc. | 21 | $18,552 |
| Shockwave Medical, Inc | 17 | $14,587 |
| Abbott | 60 | $4,069 |
| Stryker | 6 | $3,313 |
| Ancora Heart, Inc. | 12 | $2,636 |
| Philips North America LLC | 12 | $1,438 |
| Cook Research Incorporated | 3 | $1,352 |
| Boston Scientific | 55 | $1,289 |
| Livanova USA, Inc. | 5 | $915 |
| Abiomed | 11 | $396 |
| Bard Peripheral Vascular, Inc. | 8 | $339 |
| Heartflow, Inc. | 3 | $276 |
| Medtronic | 4 | $252 |
| Biotronik Inc. | 7 | $170 |
| Novartis | 9 | $157 |
| ZOLL Services LLC (a/k/a ZOLL Lifecor Corp) | 7 | $110 |
| Limflow Inc. | 1 | $110 |
| Surmodics, Inc. | 5 | $106 |
| Veryan Medical Incorporated | 5 | $101 |
| Cook Medical LLC | 5 | $88 |
| Biosense Webster, Inc. | 1 | $43 |
| Bolton Medical Inc | 1 | $42 |
| Angiodynamics, Inc. | 1 | $39 |
| Terumo Medical Corporation | 1 | $38 |
| Teleflex LLC | 2 | $35 |
| Opsens Inc. | 1 | $30 |
| Cardiva Medical, Inc. | 1 | $22 |
| Cvrx, Inc. | 1 | $22 |
| E.r. Squibb & Sons, L.L.C. | 1 | $21 |
| Cardiovascular Systems Inc. | 1 | $21 |
| Johnson & Johnson | 1 | $19 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- Edwards SAPIEN 3 Transcatheter Heart Valve$658,129
- Edwards SAPIEN 3 Ultra Transcatheter Heart Valve$52,184
- SAPIEN 3 Ultra RESILIA$34,235
- CT THROMBECTOMY SYSTEM KIT$19,286
- FLOWTRIEVER CATHETER, S$19,286
- Vascular Lithotripsy$13,511
- PASCAL$11,914
- AccuCinch$2,437
- MitraClip$1,254
- EVOQUE$1,098
- Shockwave IVL System with the Shockwave C2 Coronary IVL Catheter$800
- TandemLife$798
- Intracardiac Undivided$628
- (9525) Intracardiac Und$600
- Conformable TAG Thoracic Endoprosthesis$331
- COREVALVE EVOLUT R$159
- MitraClip System$145
- Mitra Clip system$132
- FFRct$128
- AMPLATZER$126
How this compares
$1,853,988 in reported general payments places this provider in the 95th percentile of 303 interventional cardiology providers in Illinois.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| EliquisApixaban | 96 | $110,321 |
| XareltoRivaroxaban | 32 | $49,127 |
| BrilintaTicagrelor | 24 | $25,298 |
| Repatha SureclickEvolocumab | 13 | $9,452 |
| Atorvastatin Calcium | 418 | $4,782 |
| Ezetimibe | 146 | $3,767 |
| Carvedilol | 290 | $2,782 |
| Metoprolol Succinate | 158 | $2,648 |
| Rosuvastatin Calcium | 110 | $1,904 |
| ClopidogrelClopidogrel Bisulfate | 94 | $905 |
| Lisinopril | 119 | $899 |
| Cilostazol | 27 | $897 |
| Chlorthalidone | 74 | $842 |
| Enalapril Maleate | 41 | $834 |
| Amlodipine Besylate | 122 | $695 |
Paid to pharmacies, not to this prescriber.
Companies that both paid and supply prescribed drugs
These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.
| Company | Paid to this provider | Part D cost of their drugs |
|---|---|---|
| Johnson & JohnsonXarelto | $19 | $49,12732 claims |
Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 95th percentile of 303 interventional cardiology providers in Illinois.
Other interventional cardiology in Elk Grove Village
- Jack ChamberlinElk Grove Village$153K
- Charles DavidsonChicago$5.8M
- Ravi RamanaPalos Park$2.8M
- Mark RicciardiEvanston$2.2M
- Krishna Rocha SinghSpringfield$1.7M
- Bruce LewisMaywood$1.3M
- Justin LevisayEvanston$837K
- Atman ShahChicago$794K
- Laura DavidsonChicago$661K
- Sunil AgarwalSpringfield$609K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.